Should Vasopressors Be Started Early in Septic Shock?

Abstract

Sepsis can influence blood volume, its distribution, vascular tone, and cardiac function. Persistent hypotension or the need for vasopressors after volume resuscitation is part of the definition of septic shock. Since increased positive fluid balance has been associated with increased morbidity and mortality in sepsis, timing of vasopressors in the treatment of septic shock seems crucial. However, conclusive evidence on timing and sequence of interventions with the goal to restore tissue perfusion is lacking. The aim of this narrative review is to depict the pathophysiology of hypotension in sepsis, evaluate how common interventions to treat hypotension interfere with physiology, and to give a resume of the results from clinical studies focusing on targets and timing of vasopressor in sepsis. The majority of studies comparing early versus late administration of vasopressors in septic shock are rather small, single-center, and retrospective. The range of “early” is between 1 and 12 hours. The available studies suggest a mean arterial pressure of 60 to 65 mm Hg as a threshold for increased risk of morbidity and mortality, whereas higher blood pressure targets do not seem to add further benefits. The data, albeit mostly from observational studies, speak for combining vasopressors with fluids rather “early” in the treatment of septic shock (within a 0–3-hour window). Nevertheless, the optimal resuscitation strategy should take into account the source of infection, the pathophysiology, the time and clinical course preceding the diagnosis of sepsis, and also comorbidities and sepsis-induced organ dysfunction.

Keywords

sepsis - vasopressor agents - blood volume - intravenous infusions - blood pressure - hypotension

Publikationsverlauf

Artikel online veröffentlicht:
20. September 2021

• References

• 1 Bloch A, Berger D, Takala J. Understanding circulatory failure in sepsis. Intensive Care Med 2016; 42 (12) 2077-2079
• 2 Rhodes A, Evans LE, Alhazzani W. et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43 (03) 304-377
• 3 Yealy DM, Kellum JA, Huang DT. et al; ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370 (18) 1683-1693
• 4 Mouncey PR, Osborn TM, Power GS. et al; ProMISe Trial Investigators. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015; 372 (14) 1301-1311
• 5 Peake SL, Delaney A, Bailey M. et al; ARISE Investigators, ANZICS Clinical Trials Group. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014; 371 (16) 1496-1506
• 6 Marik PE, Linde-Zwirble WT, Bittner EA, Sahatjian J, Hansell D. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database. Intensive Care Med 2017; 43 (05) 625-632
• 7 Sakr Y, Rubatto Birri PN, Kotfis K. et al; Intensive Care Over Nations Investigators. Higher fluid balance increases the risk of death from sepsis: results from a large international audit. Crit Care Med 2017; 45 (03) 386-394
• 8 Rachoin JS, Dellinger RP. Timing of norepinephrine in septic patients: NOT too little too late. Crit Care 2014; 18 (06) 691
• 9 Ospina-Tascón GA, Hernandez G, Bakker J. Should we start vasopressors very early in septic shock?. J Thorac Dis 2020; 12 (07) 3893-3896
• 10 Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early use of norepinephrine in septic shock resuscitation (CENSER): a randomized trial. Am J Respir Crit Care Med 2019; 199 (09) 1097-1105
• 11 Self WH, Semler MW, Bellomo R. et al; CLOVERS Protocol Committee and NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Network Investigators. Liberal versus restrictive intravenous fluid therapy for early septic shock: rationale for a randomized trial. Ann Emerg Med 2018; 72 (04) 457-466
• 12 Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign bundle: 2018 update. Intensive Care Med 2018; 44 (06) 925-928
• 13 Marik PE, Byrne L, van Haren F. Fluid resuscitation in sepsis: the great 30 mL per kg hoax. J Thorac Dis 2020; 12 (Suppl. 01) S37-S47
• 14 Spiegel R, Farkas JD, Rola P. et al. The 2018 Surviving Sepsis Campaign's treatment bundle: when guidelines outpace the evidence supporting their use. Ann Emerg Med 2019; 73 (04) 356-358
• 15 Corrêa TD, Vuda M, Blaser AR. et al. Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis. Crit Care Med 2012; 40 (10) 2841-2849
• 16 Christ F, Gamble J, Gartside IB, Kox WJ. Increased microvascular water permeability in patients with septic shock, assessed with venous congestion plethysmography (VCP). Intensive Care Med 1998; 24 (01) 18-27
• 17 Fleck A, Raines G, Hawker F. et al. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1985; 1 (8432): 781-784
• 18 Moller PW, Hana A, Heinisch PP. et al. The effects of vasoconstriction and volume expansion on veno-arterial ECMO flow. Shock 2019; 51 (05) 650-658
• 19 Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345 (08) 588-595
• 20 Flynn A, Chokkalingam Mani B, Mather PJ. Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms. Heart Fail Rev 2010; 15 (06) 605-611
• 21 Kumar A, Haery C, Parrillo JE. Myocardial dysfunction in septic shock: Part I. clinical manifestation of cardiovascular dysfunction. J Cardiothorac Vasc Anesth 2001; 15 (03) 364-376
• 22 Mitsuo T, Shimazaki S, Matsuda H. Right ventricular dysfunction in septic patients. Crit Care Med 1992; 20 (05) 630-634
• 23 Merz TM, Cioccari L, Frey PM. et al. Continual hemodynamic monitoring with a single-use transesophageal echocardiography probe in critically ill patients with shock: a randomized controlled clinical trial. Intensive Care Med 2019; 45 (08) 1093-1102
• 24 Chauvet JL, El-Dash S, Delastre O. et al. Early dynamic left intraventricular obstruction is associated with hypovolemia and high mortality in septic shock patients. Crit Care 2015; 19: 262
• 25 Balik M, Novotny A, Suk D. et al. Vasopressin in patients with septic shock and dynamic left ventricular outflow tract obstruction. Cardiovasc Drugs Ther 2020; 34 (05) 685-688
• 26 Asfar P, Meziani F, Hamel JF. et al; SEPSISPAM Investigators. High versus low blood-pressure target in patients with septic shock. N Engl J Med 2014; 370 (17) 1583-1593
• 27 Hernández G, Ospina-Tascón GA, Damiani LP. et al; The ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN). Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA 2019; 321 (07) 654-664
• 28 Annane D, Vignon P, Renault A. et al; CATS Study Group. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007; 370 (9588): 676-684
• 29 De Backer D, Biston P, Devriendt J. et al; SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362 (09) 779-789
• 30 Russell JA, Walley KR, Singer J. et al; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358 (09) 877-887
• 31 Li Y, Li H, Zhang D. Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis. Crit Care 2020; 24 (01) 488
• 32 Bai X, Yu W, Ji W. et al. Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care 2014; 18 (05) 532
• 33 Colon Hidalgo D, Patel J, Masic D, Park D, Rech MA. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. J Crit Care 2020; 55: 145-148
• 34 Elbouhy MA, Soliman M, Gaber A, Taema KM, Abdel-Aziz A. Early use of norepinephrine improves survival in septic shock: earlier than early. Arch Med Res 2019; 50 (06) 325-332
• 35 Ospina-Tascón GA, Hernandez G, Alvarez I. et al. Effects of very early start of norepinephrine in patients with septic shock: a propensity score-based analysis. Crit Care 2020; 24 (01) 52
• 36 Subramanian S, Yilmaz M, Rehman A, Hubmayr RD, Afessa B, Gajic O. Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study. Intensive Care Med 2008; 34 (01) 157-162
• 37 Hamzaoui O, Jozwiak M, Geffriaud T. et al. Norepinephrine exerts an inotropic effect during the early phase of human septic shock. Br J Anaesth 2018; 120 (03) 517-524
• 38 Hamzaoui O, Georger JF, Monnet X. et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care 2010; 14 (04) R142
• 39 Beck V, Chateau D, Bryson GL. et al; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group. Timing of vasopressor initiation and mortality in septic shock: a cohort study. Crit Care 2014; 18 (03) R97
• 40 Waechter J, Kumar A, Lapinsky SE. et al; Cooperative Antimicrobial Therapy of Septic Shock Database Research Group. Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study. Crit Care Med 2014; 42 (10) 2158-2168
• 41 Roberts RJ, Miano TA, Hammond DA. et al; Observation of VariatiOn in fLUids adMinistEred in shock-CHaracterizAtion of vaSoprEssor Requirements in Shock (VOLUME-CHASERS) Study Group and SCCM Discovery Network. Evaluation of vasopressor exposure and mortality in patients with septic shock. Crit Care Med 2020; 48 (10) 1445-1453
• 42 Dünser MW, Ruokonen E, Pettilä V. et al. Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care 2009; 13 (06) R181
• 43 Dünser MW, Takala J, Ulmer H. et al. Arterial blood pressure during early sepsis and outcome. Intensive Care Med 2009; 35 (07) 1225-1233
• 44 Varpula M, Tallgren M, Saukkonen K, Voipio-Pulkki LM, Pettilä V. Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005; 31 (08) 1066-1071
• 45 Vincent J-L, Nielsen ND, Shapiro NI. et al. Mean arterial pressure and mortality in patients with distributive shock: a retrospective analysis of the MIMIC-III database. Ann Intensive Care 2018; 8 (01) 107
• 46 Monnet X, Jabot J, Maizel J, Richard C, Teboul JL. Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients. Crit Care Med 2011; 39 (04) 689-694
• 47 Georger JF, Hamzaoui O, Chaari A, Maizel J, Richard C, Teboul JL. Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients. Intensive Care Med 2010; 36 (11) 1882-1889